$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

$esta Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-Q Financial Statement

#000168875719000060 Filed on November 12, 2019

Income Statement

Concept	2019 Q4	2019 Q3	2018 Q3
Revenue	$24.25M	$22.85M	$16.29M
YoY Change	47.87%	40.33%	122.36%
Cost Of Revenue	$7.890M	$8.616M	$6.173M
YoY Change	21.01%	39.58%	65.94%
Gross Profit	$16.36M	$14.24M	$10.11M
YoY Change	65.75%	40.79%	180.6%
Gross Profit Margin	67.46%	62.3%	62.1%
Selling, General & Admin	$17.13M	$19.23M	$12.99M
YoY Change	15.51%	48.07%	59.54%
% of Gross Profit	104.71%	135.04%	128.4%
Research & Development	$3.630M	$3.776M	$3.174M
YoY Change	-0.82%	18.97%	121.03%
% of Gross Profit	22.19%	26.52%	31.39%
Depreciation & Amortization	$1.080M	$21.00K	$21.00K
YoY Change	40.26%	0.0%	-96.18%
% of Gross Profit	6.6%	0.15%	0.21%
Operating Expenses	$20.76M	$23.00M	$16.16M
YoY Change	12.22%	42.35%	68.76%
Operating Profit	-$4.400M	-$8.765M	-$6.046M
YoY Change	-49.02%	44.97%	1.26%
Interest Expense	-$1.930M	$1.805M	$2.204M
YoY Change	-16.45%	-18.1%	-67.06%
% of Operating Profit
Other Income/Expense, Net	$1.030M	-$2.340M	-$1.274M
YoY Change	80.7%	83.67%	1512.66%
Pretax Income	-$5.300M	-$12.47M	$1.207M
YoY Change	-48.84%	-1132.89%	-111.34%
Income Tax	$250.0K	$308.0K	-$99.00K
% Of Pretax Income			-8.2%
Net Earnings	-$5.560M	-$12.78M	$1.306M
YoY Change	-47.1%	-1078.18%	-112.24%
Net Earnings / Revenue	-22.93%	-55.9%	8.02%
Basic Earnings Per Share		-$0.62	$0.07
Diluted Earnings Per Share	-$268.2K	-$0.62	$0.06
COMMON SHARES
Basic Shares Outstanding	20.60M shares	20.62M shares	19.15M shares
Diluted Shares Outstanding		20.62M shares	20.12M shares

Balance Sheet

Concept	2019 Q4	2019 Q3	2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$37.70M	$42.60M	$65.60M
YoY Change	-28.33%	-35.06%
Cash & Equivalents	$37.66M	$42.56M	$65.58M
Short-Term Investments
Other Short-Term Assets	$6.800M	$7.000M	$5.600M
YoY Change	58.14%	25.0%
Inventory	$28.66M	$26.39M	$15.37M
Prepaid Expenses
Receivables	$22.77M	$22.02M	$18.25M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$95.84M	$97.94M	$104.8M
YoY Change	-3.62%	-6.54%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.42M	$16.65M	$12.89M
YoY Change	27.14%	29.15%
Goodwill	$465.0K	$465.0K	$465.0K
YoY Change	0.0%	0.0%
Intangibles	$3.441M	$2.893M	$2.970M
YoY Change	-0.12%	-2.59%
Long-Term Investments
YoY Change
Other Assets	$368.0K	$312.0K	$283.0K
YoY Change	16.83%	10.25%
Total Long-Term Assets	$20.69M	$20.32M	$16.69M
YoY Change	20.74%	21.79%
TOTAL ASSETS
Total Short-Term Assets	$95.84M	$97.94M	$104.8M
Total Long-Term Assets	$20.69M	$20.32M	$16.69M
Total Assets	$116.5M	$118.3M	$121.5M
YoY Change	-0.04%	-2.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.37M	$9.383M	$5.492M
YoY Change	66.15%	70.85%
Accrued Expenses	$10.68M	$9.866M	$5.861M
YoY Change	74.32%	68.33%
Deferred Revenue	$785.0K	$719.0K
YoY Change	-13.55%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$300.0K	$400.0K	$300.0K
YoY Change	0.0%	33.33%
Total Short-Term Liabilities	$23.24M	$20.35M	$14.85M
YoY Change	41.31%	37.0%
LONG-TERM LIABILITIES
Long-Term Debt	$48.14M	$47.80M	$21.50M
YoY Change	115.88%	122.33%
Other Long-Term Liabilities	$2.461M	$3.055M	$3.431M
YoY Change	-30.7%	-10.96%
Total Long-Term Liabilities	$50.60M	$3.055M	$3.431M
YoY Change	1325.04%	-10.96%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.24M	$20.35M	$14.85M
Total Long-Term Liabilities	$50.60M	$3.055M	$3.431M
Total Liabilities	$76.92M	$74.45M	$44.49M
YoY Change	63.35%	67.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$127.1M	-$121.6M	-$78.46M
YoY Change	42.88%	54.94%
Common Stock	$147.7M	$147.2M
YoY Change	1.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.854M	$2.854M	$2.854M
YoY Change	0.0%	0.0%
Treasury Stock Shares	408.1K shares	408.1K shares	408.1K shares
Shareholders Equity	$39.61M	$43.80M	$76.99M
YoY Change
Total Liabilities & Shareholders Equity	$116.5M	$118.3M	$121.5M
YoY Change	-0.04%	-2.65%

Cashflow Statement

Concept	2019 Q4	2019 Q3	2018 Q3
OPERATING ACTIVITIES
Net Income	-$5.560M	-$12.78M	$1.306M
YoY Change	-47.1%	-1078.18%	-112.24%
Depreciation, Depletion And Amortization	$1.080M	$21.00K	$21.00K
YoY Change	40.26%	0.0%	-96.18%
Cash From Operating Activities	-$4.020M	-$10.90M	-$10.50M
YoY Change	-52.59%	3.81%	16.28%
INVESTING ACTIVITIES
Capital Expenditures	-$1.360M	-$740.0K	-$570.0K
YoY Change	189.36%	29.82%	54.05%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change	-100.0%
Cash From Investing Activities	-$1.360M	-$740.0K	-$570.0K
YoY Change	-69.3%	29.82%	54.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	370.0K	22.46M	65.29M
YoY Change	-716.67%	-65.6%	393.13%
NET CHANGE
Cash From Operating Activities	-4.020M	-10.90M	-10.50M
Cash From Investing Activities	-1.360M	-740.0K	-570.0K
Cash From Financing Activities	370.0K	22.46M	65.29M
Net Change In Cash	-5.010M	10.82M	54.22M
YoY Change	-61.37%	-80.04%	1311.98%
FREE CASH FLOW
Cash From Operating Activities	-$4.020M	-$10.90M	-$10.50M
Capital Expenditures	-$1.360M	-$740.0K	-$570.0K
Free Cash Flow	-$2.660M	-$10.16M	-$9.930M
YoY Change	-66.79%	2.32%	14.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	674000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	714000	USD
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-169000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Period End Date DocumentPeriodEndDate	2019-09-30
	dei	Document Type DocumentType	10-Q
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-140000	USD
	esta	Allocated Sharebased Compensation Expense And Issuance Of Stock And Warrants For Services Or Claims AllocatedSharebasedCompensationExpenseAndIssuanceOfStockAndWarrantsForServicesOrClaims	5174000	USD
	dei	Entity Central Index Key EntityCentralIndexKey	0001688757
CY2019Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20600513	shares
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Establishment Labs Holdings Inc.
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
CY2018Q4	esta	Accrued Stock Option Grant Bonus Current AccruedStockOptionGrantBonusCurrent	1763000	USD
CY2019Q3	esta	Accrued Stock Option Grant Bonus Current AccruedStockOptionGrantBonusCurrent	3600000	USD
CY2018Q4	esta	Advisory Board And Board Of Director Liabilities Current AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent	165000	USD
CY2019Q3	esta	Advisory Board And Board Of Director Liabilities Current AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent	86000	USD
CY2018Q3	esta	Allocated Sharebased Compensation Expense And Issuance Of Stock And Warrants For Services Or Claims AllocatedSharebasedCompensationExpenseAndIssuanceOfStockAndWarrantsForServicesOrClaims	2754000	USD
	esta	Allocated Sharebased Compensation Expense And Issuance Of Stock And Warrants For Services Or Claims AllocatedSharebasedCompensationExpenseAndIssuanceOfStockAndWarrantsForServicesOrClaims	4966000	USD
CY2019Q3	esta	Allocated Sharebased Compensation Expense And Issuance Of Stock And Warrants For Services Or Claims AllocatedSharebasedCompensationExpenseAndIssuanceOfStockAndWarrantsForServicesOrClaims	1444000	USD
CY2018Q4	esta	Cash Payable For Asset Acquisition Current CashPayableForAssetAcquisitionCurrent	0	USD
CY2019Q3	esta	Cash Payable For Asset Acquisition Current CashPayableForAssetAcquisitionCurrent	378000	USD
CY2018Q4	esta	Cash Payable For Asset Acquisition Noncurrent CashPayableForAssetAcquisitionNoncurrent	883000	USD
CY2019Q3	esta	Cash Payable For Asset Acquisition Noncurrent CashPayableForAssetAcquisitionNoncurrent	850000	USD
CY2018Q4	esta	Class Of Warrant Or Right Outstanding Current ClassOfWarrantOrRightOutstandingCurrent	2261000	USD
CY2019Q3	esta	Class Of Warrant Or Right Outstanding Current ClassOfWarrantOrRightOutstandingCurrent	0	USD
	esta	Deferred Offering Expense DeferredOfferingExpense	-1468000	USD
	esta	Deferred Offering Expense DeferredOfferingExpense	0	USD
CY2018Q3	esta	Depreciation And Amortization Property Plant And Equipment DepreciationAndAmortizationPropertyPlantAndEquipment	500000	USD
	esta	Depreciation And Amortization Property Plant And Equipment DepreciationAndAmortizationPropertyPlantAndEquipment	1600000	USD
CY2019Q3	esta	Depreciation And Amortization Property Plant And Equipment DepreciationAndAmortizationPropertyPlantAndEquipment	600000	USD
	esta	Depreciation And Amortization Property Plant And Equipment DepreciationAndAmortizationPropertyPlantAndEquipment	1900000	USD
	esta	Depreciationand Amortization Excluding Debt Discount Premium DepreciationandAmortizationExcludingDebtDiscountPremium	2041000	USD
	esta	Depreciationand Amortization Excluding Debt Discount Premium DepreciationandAmortizationExcludingDebtDiscountPremium	2210000	USD
	esta	Employee And Non Employee Service Sharebased Compensation Nonvested Awards Compensation Cost Notyet Recognized Periodfor Recognition EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition	P2Y6M
CY2018Q4	esta	Line Of Credit Including Interest Payable Current LineOfCreditIncludingInterestPayableCurrent	22322000	USD
CY2019Q3	esta	Line Of Credit Including Interest Payable Current LineOfCreditIncludingInterestPayableCurrent	47770000	USD
	esta	Noncash Consideration Payable Relatedto Asset Acquisition NoncashConsiderationPayableRelatedtoAssetAcquisition	0	USD
	esta	Noncash Consideration Payable Relatedto Asset Acquisition NoncashConsiderationPayableRelatedtoAssetAcquisition	1234000	USD
	esta	Noncash Deferred Offering Expense NoncashDeferredOfferingExpense	0	USD
	esta	Noncash Deferred Offering Expense NoncashDeferredOfferingExpense	337000	USD
CY2019Q3	esta	Number Of Manufacturing Facilities NumberOfManufacturingFacilities	2	facility
	esta	Paymentsto Acquire Assets Including Receivables Held PaymentstoAcquireAssetsIncludingReceivablesHeld	0	USD
	esta	Paymentsto Acquire Assets Including Receivables Held PaymentstoAcquireAssetsIncludingReceivablesHeld	767000	USD
	esta	Revenue From Contract With Customer Product Return Period RevenueFromContractWithCustomerProductReturnPeriod	P15D
	esta	Revenue From Contract With Customer Product Shelf Life RevenueFromContractWithCustomerProductShelfLife	P5Y
	esta	Sharebased Compensation And Issuance Of Stock Or Warrants For Services And Claims SharebasedCompensationAndIssuanceOfStockOrWarrantsForServicesAndClaims	4966000	USD
	esta	Sharebased Compensation And Issuance Of Stock Or Warrants For Services And Claims SharebasedCompensationAndIssuanceOfStockOrWarrantsForServicesAndClaims	5174000	USD
	esta	Stock Issued During Period Shares Warrant Exercises StockIssuedDuringPeriodSharesWarrantExercises	92231	shares
CY2018Q3	esta	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	121000	USD
CY2019Q1	esta	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	56000	USD
CY2019Q2	esta	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	0	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6239000	USD
CY2019Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	9383000	USD
CY2018Q4	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	0	USD
CY2018Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1295000	USD
CY2019Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1569000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17648000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6125000	USD
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9866000	USD
CY2019Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22022000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	926000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	449000	USD
CY2019Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1021000	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	122000	USD
CY2019Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	167000	USD
CY2018Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1300000	USD
CY2019Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	2472000	USD
CY2018Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	487000	USD
CY2019Q3	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	502000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5230000	USD
CY2019Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6798000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15156000	USD
CY2019Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19998000	USD
CY2019Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	56000	USD
CY2019Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	35000	USD
CY2019Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	43000	USD
CY2019Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	959000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2482000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2056000	USD
CY2018Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	500000	USD
CY2019Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	600000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1969373	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1881690	shares
CY2018	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2018Q4	us-gaap	Assets Assets	116573000	USD
CY2019Q3	us-gaap	Assets Assets	118256000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	99435000	USD
CY2019Q3	us-gaap	Assets Current AssetsCurrent	97936000	USD
CY2018Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	694000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1446000	USD
CY2019Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-205000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-567000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	914000	USD
CY2019Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	914000	USD
CY2019Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	630000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	645000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	540000	USD
CY2018Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	336000	USD
CY2019Q3	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	357000	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	50000	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	69000	USD
CY2019Q3	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	183000	USD
CY2018Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	1400000	USD
CY2019Q3	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	1500000	USD
CY2019Q3	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	540000	USD
CY2019Q3	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	36000	USD
CY2019Q3	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	169000	USD
CY2019Q3	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	491000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	42559000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	54713000	USD
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20672025	shares
CY2019Q3	us-gaap	Capital Leases Future Minimum Payments Remainder Of Fiscal Year CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear	77000	USD
CY2018Q4	us-gaap	Cash Cash	52639000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-10080000	USD
CY2018Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	USD
CY2019Q3	us-gaap	Cash Cash	42559000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10864000	USD
CY2019Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	USD
CY2019Q3	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	258000	USD
CY2019Q3	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	49000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	65577000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52639000	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	3020460	shares
CY2019Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	3651898	shares
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2019Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20983139	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20263955	shares
CY2019Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20575069	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	145709000	USD
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	147208000	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1506000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9861000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12116000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-32022000	USD
CY2018Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	52000	USD
CY2019Q3	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	45000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	908000	USD
CY2019Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	719000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1186000	USD
CY2019Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1265000	USD
CY2018Q3	us-gaap	Cost Of Revenue CostOfRevenue	6173000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	18566000	USD
CY2019Q3	us-gaap	Cost Of Revenue CostOfRevenue	8616000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	26814000	USD
CY2018Q3	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1500000	USD
CY2018Q3	us-gaap	Depreciation Depreciation	21000	USD
	us-gaap	Depreciation Depreciation	69000	USD
CY2019Q3	us-gaap	Depreciation Depreciation	21000	USD
	us-gaap	Depreciation Depreciation	63000	USD
CY2018Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	4768000	USD
CY2019Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3281000	USD
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.66
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.59
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2019Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	7700000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1213000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1782000	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.66
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.59
CY2019Q3	us-gaap	Gross Profit GrossProfit	14238000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2602000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3200000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	583000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	177000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	109000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	345000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2600000	USD
CY2019Q3	us-gaap	Goodwill Goodwill	465000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-76000	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	10113000	USD
	us-gaap	Gross Profit GrossProfit	26245000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-75000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	465000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-2102000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-2890000	USD
CY2018Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	11420000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	15945000	USD
CY2019Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	235000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	2843000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2018	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Gross Profit GrossProfit	38502000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1207000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10521000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12467000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-32207000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-99000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	63000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	308000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	387000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	89000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	201000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2460000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3683000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5867000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5279000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3674000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3964000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3346000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2007000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	13000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	3000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-191000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	256000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3811000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2949000	USD
CY2018Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	291000	USD
CY2019Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	291000	USD
CY2018Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	4658000	USD
CY2019Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	4675000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3445000	USD
CY2019Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2893000	USD
CY2018Q3	us-gaap	Interest Expense InterestExpense	2204000	USD
	us-gaap	Interest Expense InterestExpense	6548000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	1805000	USD
	us-gaap	Interest Expense InterestExpense	6568000	USD
	us-gaap	Interest Paid Net InterestPaidNet	3975000	USD
	us-gaap	Interest Paid Net InterestPaidNet	4192000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	20252000	USD
CY2019Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	20921000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
	us-gaap	Inventory Write Down InventoryWriteDown	-93000	USD
CY2018Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	5000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	9000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	24845000	USD
CY2019Q3	us-gaap	Inventory Net InventoryNet	26387000	USD
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3349000	USD
CY2019Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4160000	USD
CY2018Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	200000	USD
CY2019Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	300000	USD
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1244000	USD
CY2019Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1306000	USD
CY2019Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	13000	USD
CY2018Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	300000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	700000	USD
CY2019Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	300000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	900000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	47088000	USD
CY2019Q3	us-gaap	Liabilities Liabilities	74452000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	116573000	USD
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	118256000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16447000	USD
CY2019Q3	us-gaap	Liabilities Current LiabilitiesCurrent	20346000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	81587000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22424000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1300000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6407000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-25405000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-25957000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-6530000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-5360000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	1306000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-10584000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-10779000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-9040000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-12775000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-32594000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	1257000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reportingunit
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	16159000	USD
	us-gaap	Operating Expenses OperatingExpenses	41488000	USD
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	23003000	USD
	us-gaap	Operating Expenses OperatingExpenses	65038000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6046000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-15243000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3748000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	373000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	405000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	467000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8765000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-26536000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	30000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	603000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1734000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	166000	USD
CY2019Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	854000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	315000	USD
CY2019Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	312000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-6000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	529000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	200000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	723000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	67000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-154000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	659000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	572000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	200000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	723000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	659000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	572000	USD
CY2018Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4083000	USD
CY2019Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1097000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3551000	USD
CY2019Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3055000	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1274000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3238000	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2340000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2526000	USD
CY2018Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	568000	USD
CY2019Q3	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	310000	USD
CY2017Q3	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	4700000	USD
	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	0	USD
	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	2261000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	135000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	41000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	17000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1259000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5623000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4303000	USD
CY2019Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6968000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	24748000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	616000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	278000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	121000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	58000	USD
CY2018Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	148000	USD
CY2019Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	259000	USD
	us-gaap	Property Plant And Equipment Estimated Useful Lives PropertyPlantAndEquipmentEstimatedUsefulLives	P50Y
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18143000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23448000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12913000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16650000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	25000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	70000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	226000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	264000	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	5083000	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3174000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9026000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3776000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11361000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-88975000	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-121569000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16286000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	44811000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22854000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	65316000	USD
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12985000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	32462000	USD
CY2019Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	19227000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	53677000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	700000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	16.14
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	26796	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	439000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	13.57
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	23778000	USD
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	11470000	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1486363	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1845517	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.43
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.63
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	7900000	USD
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	705475	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	8.08
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.23
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	24.39
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y8M27D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y2M27D
	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2018Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0	USD
	us-gaap	Stock Issued1 StockIssued1	630000	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	53050	shares
CY2018Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1610000	USD
CY2018Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14492000	USD
CY2018Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	70055000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	630000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	337000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	743000	USD
CY2018Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1470000	USD
CY2018Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2754000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1836000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1894000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1444000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	436000	USD
CY2018Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2018Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	180000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	84000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	92000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	102000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-5013000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	-8760000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	2371000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	76987000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	69485000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	61030000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	53787000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	43804000	USD
CY2018Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	479000	USD
CY2019Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	0	USD
CY2018Q3	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	0	USD
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	408070	shares
CY2019Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	408070	shares
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2854000	USD
CY2019Q3	us-gaap	Treasury Stock Value TreasuryStockValue	2854000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	15945000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	2843000	USD
CY2018Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	2300000	USD
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20123297	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16146675	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20620828	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20478603	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19152995	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16146675	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20620828	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20478603	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk and Other Risks and Uncertainties</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#231f20;">Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and accounts receivable. The majority of the Company’s cash is held at two financial institutions in the United States. The Company has not experienced any losses to its deposits of cash.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#231f20;">All of the Company’s revenue has been derived from sales of its products in international markets, principally Europe, the Middle East, Latin America, and Asia. In the international markets in which the Company participates, the Company uses a combination of distributors and makes direct sales to customers. The Company performs ongoing credit evaluations of its distributors and customers, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">During the </font><font style="font-family:Arial;font-size:10pt;">nine</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;">September 30, 2019</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2018</font><font style="font-family:Arial;font-size:10pt;">, no customers accounted for more than 10% of the Company’s revenue. Substantially all of the Company’s revenues are derived from the sale of Motiva Implants. </font><font style="font-family:Arial;font-size:10pt;">One</font><font style="font-family:Arial;font-size:10pt;"> customer accounted for </font><font style="font-family:Arial;font-size:10pt;">14.0%</font><font style="font-family:Arial;font-size:10pt;"> and another customer accounted for </font><font style="font-family:Arial;font-size:10pt;">11.2%</font><font style="font-family:Arial;font-size:10pt;"> of the Company’s accounts receivable balance as of September 30, 2019. No customers accounted for more than 10% of the Company’s accounts receivable balance as of </font><font style="font-family:Arial;font-size:10pt;color:#231f20;">December 31, 2018</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company relies on NuSil Technology, LLC, or NuSil, as the sole supplier of medical-grade silicone used in Motiva Implants. During the </font><font style="font-family:Arial;font-size:10pt;">nine</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;">September 30, 2019</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2018</font><font style="font-family:Arial;font-size:10pt;">, the Company had purchases of </font><font style="font-family:Arial;font-size:10pt;">$12.6 million</font><font style="font-family:Arial;font-size:10pt;">, or </font><font style="font-family:Arial;font-size:10pt;">60.3%</font><font style="font-family:Arial;font-size:10pt;"> of total purchases, and </font><font style="font-family:Arial;font-size:10pt;">$10.6 million</font><font style="font-family:Arial;font-size:10pt;">, or </font><font style="font-family:Arial;font-size:10pt;">64.9%</font><font style="font-family:Arial;font-size:10pt;"> of total purchases, respectively, from NuSil. As of </font><font style="font-family:Arial;font-size:10pt;">September 30, 2019</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;color:#231f20;">December 31, 2018</font><font style="font-family:Arial;font-size:10pt;">, we had an outstanding balance owed to this vendor of </font><font style="font-family:Arial;font-size:10pt;">$2.1 million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$0.8 million</font><font style="font-family:Arial;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company’s future results of operations involve a number of risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, uncertainty of regulatory approval of the Company’s current and potential future products, uncertainty of market acceptance of the Company’s products, competition from substitute products and larger companies, securing and protecting proprietary technology, strategic relationships and dependence on key individuals and sole source suppliers. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Products developed by the Company require clearances from the FDA or other international regulatory agencies prior to commercial sales. There can be no assurance that the products will receive the necessary clearances. If the Company was denied clearance, clearance was delayed, or the Company was unable to maintain its existing clearances, these developments could have a material adverse impact on the Company.</font></div></div>
	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Debt and Embedded Derivatives</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company applies the accounting standards for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts. The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Debt with Conversion and Other Options</font><font style="font-family:Arial;font-size:10pt;"> (see Note 6).</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company uses option pricing valuation models to determine the fair value of embedded derivatives and records any change in fair value as a component of other income or expense in the condensed consolidated statements of operations (see Note 5).</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#231f20;">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Significant accounting </font><font style="font-family:Arial;font-size:10pt;">estimates and management judgments reflected in the condensed </font><font style="font-family:Arial;font-size:10pt;color:#231f20;">consolidated</font><font style="font-family:Arial;font-size:10pt;"> financial statements include items such as accounts receivable valuation and allowances, inventory valuation and allowances, valuation of acquired intangible assets, valuation of derivatives, estimation of assets’ useful lives and valuation of deferred income tax assets, including tax valuation allowances. Estimates are based</font><font style="font-family:Arial;font-size:10pt;color:#231f20;"> on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.</font></div></div>

Files In Submission

Name	View Source	Status
0001688757-19-000060-index-headers.html	Edgar Link	pending
0001688757-19-000060-index.html	Edgar Link	pending
0001688757-19-000060.txt	Edgar Link	pending
0001688757-19-000060-xbrl.zip	Edgar Link	pending
esta-20190930.xml	Edgar Link	completed
esta-20190930.xsd	Edgar Link	pending
esta-20190930_cal.xml	Edgar Link	unprocessable
esta-20190930_def.xml	Edgar Link	unprocessable
esta-20190930_lab.xml	Edgar Link	unprocessable
esta-20190930_pre.xml	Edgar Link	unprocessable
establishmentlabs10q_2019q3.htm	Edgar Link	pending
exhibit311q32019.htm	Edgar Link	pending
exhibit312q32019.htm	Edgar Link	pending
exhibit321q32019.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

2019 Q4 Form 10-Q Financial Statement

#000168875719000060 Filed on November 12, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ESTA ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

2019 Q4 Form 10-Q Financial Statement

#000168875719000060 Filed on November 12, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta